Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 13, 2018, during market hours
10-Q filed Aug 13, 2018, 44 days after period end · 0001171843-18-006008
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $252.50K | $2.50K | $2.50K | $2.50K |
| Net Income | -$627.05K | -$4.65M | -$3.85M | -$5.45M |
| EPS Diluted | -$0.83 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.39 |
| -$0.47 |
| -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
